Morning Market Losers

shares fell 45.95 percent to $11.01 after the company reported weaker-than-expected Q3 results and issued a downbeat outlook.

shares declined 38.40 percent to $3.30 after the company reported that it has suspended the clinical dosing of APTO-253 to review its drug manufacturing processes and procedures.

shares dipped 30.70 percent to $19.25 after the company reported downbeat Q3 earnings and issued a weak outlook.

fell 23.07 percent to $29.17 after the company reported Q2 results.

shares dipped 11.25 percent to $2.13 after the company reported the pricing of $9.8 million registered direct offering.

fell 9.44 percent to $2.59. JP Morgan downgraded SunEdison from Overweight to Neutral and lowered the price target from $19.00 to $5.50.

declined 9.28 percent to $65.94. Baird downgraded American Woodmark from Outperform to Neutral.

shares dropped 6.51 percent to $96.40 following the FDA staff review related to company's drisapersen.

shares declined 5.41 percent to $4.55. Destination XL Group reported Q3 adjusted loss of $0.07 per share on revenue of $99.6 million.

shares declined 3.17 percent to $13.13. Builders FirstSource reported an offering of 7 million shares via selling holders.

shares dropped 2.63 percent to $18.88.

withdrew its offer to acquire Depomed following court ruling.

shares slipped 2.07 percent to $2.36 after the company reported senior management changes. MannKind reported that Hakan Edstrom has stepped down as CEO. The company named Alfred Mann as interim CEO.